The Safety Rates Drug Report

Member Login
2004.Q1    2004.Q2    2004.Q3    2004.Q4    2005.Q1    2005.Q2    2005.Q3    2005.Q4    2006.Q1    2006.Q2    2006.Q3    2006.Q4    2007.Q1    2007.Q2    2007.Q3    2007.Q4    2008.Q1    2008.Q2    2008.Q3    2008.Q4    2009.Q1    2009.Q2    2009.Q3    2009.Q4    2010.Q1    2010.Q2    2010.Q3    2010.Q4    2011.Q1    2011.Q2    2011.Q3    2011.Q4    2012.Q1    2012.Q2    2012.Q3    2012.Q4    2013.Q1    2013.Q2    2013.Q3    2013.Q4    2014.Q1    2014.Q2    2014.Q3    2014.Q4    2015.Q1    2015.Q2    2015.Q3    2015.Q4    2016.Q1    2016.Q2    2016.Q3   

Drug     Injury     Quarter    

Drug: vincristine     Quarter: 2016Q3

Total Records: 1,179     Number of Pages: 59

DRUGNAME PT EventCount
VINCRISTINE Malaise 7
Vincristine Myelodysplastic syndrome 7
VINCRISTINE Oesophageal candidiasis 7
vincristine Pericardial effusion 7
VINCRISTINE Polyneuropathy 7
vincristine Precursor B-lymphoblastic lymphoma refractory 7
VINCRISTINE Progressive multifocal leukoencephalopathy 7
VINCRISTINE Pulmonary toxicity 7
Vincristine Renal impairment 7
vincristine Streptococcal bacteraemia 7
vincristine Therapy non-responder 7
VINCRISTINE Tumour lysis syndrome 7
vincristine Viraemia 7
VINCRISTINE HOSPIRA Febrile bone marrow aplasia 7
VINCRISTINE SULFATE. Decreased appetite 7
VINCRISTINE SULFATE. Infection 7
VINCRISTINE SULFATE. Posterior reversible encephalopathy syndrome 7
vincristine Blood bilirubin decreased 6
vincristine Blood immunoglobulin G increased 6
vincristine Blood lactate dehydrogenase increased 6

Total Records: 1,179     Number of Pages: 59